Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Trepo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Gastroenterology|July 5, 2016
ReplyPierre Deltenre, Eric Trepo, Christophe Moreno
Hepatology (Baltimore, Md.)|December 14, 2011
PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosisEric Trepo, Erwan Guyot, Nathalie Ganne-Carrie, et al.
Hepatology (Baltimore, Md.)|May 28, 2021
Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver DiseaseLukas Otero Sanchez, Eleni Karakike, Hassane Njimi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2015
Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control studyOlivier Lheureux, Eric Trepo, Maya Hites, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis CPierre Pradat, Eric Trepo, Andrej Potthoff, et al.
Journal of Hepatology|March 8, 2020
Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitisLaura Weichselbaum, Abdulkader Azouz, Kinga K Smolen, et al.
Alcoholism, Clinical and Experimental Research|February 6, 2020
Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver DiseaseElena Palma, Antonio Riva, Christophe Moreno, et al.
Diabetes|September 21, 2017
JNK Activation of BIM Promotes Hepatic Oxidative Stress, Steatosis, and Insulin Resistance in ObesitySara A Litwak, Lokman Pang, Sandra Galic, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumabErwan Vo-Quang, Claudia Campani, Manon Allaire, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2025
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 studyJean-Charles Nault, Nanthara Sritharan, Gontran Verset, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Gastroenterology|July 5, 2016
ReplyPierre Deltenre, Eric Trepo, Christophe Moreno
Hepatology (Baltimore, Md.)|December 14, 2011
PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosisEric Trepo, Erwan Guyot, Nathalie Ganne-Carrie, et al.
Hepatology (Baltimore, Md.)|May 28, 2021
Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver DiseaseLukas Otero Sanchez, Eleni Karakike, Hassane Njimi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2015
Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control studyOlivier Lheureux, Eric Trepo, Maya Hites, et al.
Hepatology (Baltimore, Md.)|October 14, 2009
The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis CPierre Pradat, Eric Trepo, Andrej Potthoff, et al.
Journal of Hepatology|March 8, 2020
Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitisLaura Weichselbaum, Abdulkader Azouz, Kinga K Smolen, et al.
Alcoholism, Clinical and Experimental Research|February 6, 2020
Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver DiseaseElena Palma, Antonio Riva, Christophe Moreno, et al.
Diabetes|September 21, 2017
JNK Activation of BIM Promotes Hepatic Oxidative Stress, Steatosis, and Insulin Resistance in ObesitySara A Litwak, Lokman Pang, Sandra Galic, et al.
European Journal of Cancer (Oxford, England : 1990)|April 5, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumabErwan Vo-Quang, Claudia Campani, Manon Allaire, et al.
JHEP Reports : Innovation in Hepatology|January 1, 2025
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 studyJean-Charles Nault, Nanthara Sritharan, Gontran Verset, et al.
Pageof 2